CFDE Data Portal | Search MSTN

	Label	Description
	MSTN Gene (Entity type)	ENSG00000138379 - myostatin
	MSTN associations Collection (Entity type)	Associations for MSTN_associations
	MSTN associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE147876,GSE147877 2 V 7 ENZALUTAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE119007 prostaglandin TS-A clone E2 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE171837 3 V 1 BORTEZOMIB MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE152699 GSE152723 vemurafenib 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 prednisolone muscle organ 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

MSTN

ENSG00000138379 - myostatin

MSTN associations

Associations for MSTN_associations

MSTN associations.tsv

A file from IDG as part of the Harmonizome project

GSE147876,GSE147877 2 V 7 ENZALUTAMIDE HUMAN UP

A Gene Set from LINCS

GSE119007 prostaglandin TS-A clone E2 1 v 0 human dn

A Gene Set from LINCS

GSE77108 saha 6 v 2 human dn

A Gene Set from LINCS

GSE171837 3 V 1 BORTEZOMIB MOUSE DN

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up

A Gene Set from LINCS

GSE152699 GSE152723 vemurafenib 3 v 2 human up

A Gene Set from LINCS

GSE164874 prednisolone muscle organ 5 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.